Digoxin Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 62.5 mcg, 125 mcg, 250 mcg
Reference Brands: Lanoxin(US & EU)
Category:
Critical Care
Digoxin is a key cardiac drug for heart failure and atrial fibrillation, available as oral tablets, oral solution, and 250 mcg/mL IV injection. Brands include Lanoxin and Digoxin Hameln. It is widely supplied to hospitals and clinics via pharma B2B procurement networks and institutional cardiac care supply chains.
Digoxin is available in Tablets
and strengths such as 62.5 mcg, 125 mcg, 250 mcg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Digoxin is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Digoxin can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Digoxin is a cardiac glycoside used in the treatment of heart failure and atrial fibrillation. It enhances myocardial contractility while controlling ventricular rate by inhibiting the sodium-potassium ATPase pump. Available in oral tablets (62.5, 125, and 250 mcg), oral solution (50 mcg/mL), and IV injection (250 mcg/mL), Digoxin is widely used in both acute and chronic cardiac care. In the US, Lanoxin and Pfizer’s generic injections are common, while EU brands include Lanoxin, Digoxin Hameln, and Meda. Hospitals, cardiology centers, and clinics procure Digoxin regularly through pharma B2B platforms and hospital group purchasing organizations.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing